Back

The difference of long-term outcome by the anti-arrhythmic drug after pulmonary vein isolation for non-paroxysmal atrial fibrillation; sub-analysis of EAST-AF trial

26 August 2018 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 2 - Atrial fibrillation ablation Rhythm Control, Catheter Ablation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Kazuaki Kaitani

Japanese Red Cross Otsu Hospital, Otsu (Japan)

29 More presentations in this session

Presentation thumbnail
Professor Y. Oh (Seoul, KR)
Abstract Slides
Presentation thumbnail
Associate Professor H. Yu (Seoul, KR)
Abstract
Presentation thumbnail
Doctor S. Otuki (Osaka, JP)
Abstract
Presentation thumbnail
Doctor V. Rubesch-Kuetemeyer (Detmold, DE)
Abstract Slides
Presentation thumbnail
Professor G. Conte (Lugano, CH)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Atrial fibrillation ablation

The Event

Event poster

ESC Congress 2018

26 August 2018 08:30 CET
You may be interested in
thumbnail
Congress Session
Update on antiarrhythmic therapy
31 March 2025
thumbnail
Congress Presentation
Relationship of the duration of pulmonary vein isolation-refractory non-paroxysmal atrial fibrillation to the middle- to long-term outcome of the ExTRa Mapping-guided ablation.
2 September 2019
thumbnail
Congress Presentation
Generalizability of the EAST-AFNET 4 trial: assessing outcomes of early rhythm-control therapy in patients with atrial fibrillation
27 August 2021
thumbnail
Congress Presentation
Electrical cardioversion of long-standing persistent atrial fibrillation: the importance of antiarrhythmic pretreatment
14 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources